The text focuses on new measures adopted by the EU to enhance the availability and security of critical medicines within the region. The main points include boosting investment in manufacturing capacity, establishing a critical medicines security fund, promoting cross-border procurements, and coordinating national stockpiles. The conclusion emphasizes the importance of these actions in strengthening health security and reducing dependency on external suppliers to ensure fair access to essential medicines.